Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Barth

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Proteins|June 27, 2012
Design of human granzyme B variants resistant to serpin B9Valeria Losasso, Sonja Schiffer, Stefan Barth, et al.
Nucleic Acid Therapeutics|April 3, 2013
An aptamer-siRNA chimera silences the eukaryotic elongation factor 2 gene and induces apoptosis in cancers expressing αvβ3 integrinAhmad Fawzi Hussain, Mehmet Kemal Tur, Stefan Barth
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 12, 2011
Cetuximab induces mitochondrial translocalization of EGFRvIII, but not EGFR: involvement of mitochondria in tumor drug resistance?Agnieszka Dreier, Stefan Barth, Anand Goswami, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 20, 2009
Targeted delivery of short interfering RNAs--strategies for in vivo deliveryUlrich Wullner, Inga Neef, Mehmet K Tur, et al.
Expert Opinion on Therapeutic Targets|December 13, 2012
Targeting the fetal acetylcholine receptor in rhabdomyosarcomaKatja Simon-Keller, Stefan Barth, Angela Vincent, et al.
Journal of Leukocyte Biology|August 14, 2014
Assessment of the neutrophilic antibody-dependent respiratory burst (ADRB) response to Plasmodium falciparumStephanie Kapelski, Torsten Klockenbring, Rainer Fischer, et al.
Protein Science : a Publication of the Protein Society|April 26, 2016
Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulationsXiaojing Cong, Christian Cremer, Thomas Nachreiner, et al.
Immunology and Cell Biology|January 9, 2016
Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophagesDmitrij Hristodorov, Radoslav Mladenov, Rainer Fischer, et al.
Plos One|January 23, 2016
Development of a Competitive Cystatin C-Specific Bioassay Suitable for Repetitive MeasurementsTatjana Damm, Holger Spiegel, Stefan Barth, et al.
Toxins|October 30, 2012
Macrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseasesDmitrij Hristodorov, Radoslav Mladenov, Michael Huhn, et al.
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Proteins|June 27, 2012
Design of human granzyme B variants resistant to serpin B9Valeria Losasso, Sonja Schiffer, Stefan Barth, et al.
Nucleic Acid Therapeutics|April 3, 2013
An aptamer-siRNA chimera silences the eukaryotic elongation factor 2 gene and induces apoptosis in cancers expressing αvβ3 integrinAhmad Fawzi Hussain, Mehmet Kemal Tur, Stefan Barth
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 12, 2011
Cetuximab induces mitochondrial translocalization of EGFRvIII, but not EGFR: involvement of mitochondria in tumor drug resistance?Agnieszka Dreier, Stefan Barth, Anand Goswami, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 20, 2009
Targeted delivery of short interfering RNAs--strategies for in vivo deliveryUlrich Wullner, Inga Neef, Mehmet K Tur, et al.
Expert Opinion on Therapeutic Targets|December 13, 2012
Targeting the fetal acetylcholine receptor in rhabdomyosarcomaKatja Simon-Keller, Stefan Barth, Angela Vincent, et al.
Journal of Leukocyte Biology|August 14, 2014
Assessment of the neutrophilic antibody-dependent respiratory burst (ADRB) response to Plasmodium falciparumStephanie Kapelski, Torsten Klockenbring, Rainer Fischer, et al.
Protein Science : a Publication of the Protein Society|April 26, 2016
Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulationsXiaojing Cong, Christian Cremer, Thomas Nachreiner, et al.
Immunology and Cell Biology|January 9, 2016
Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophagesDmitrij Hristodorov, Radoslav Mladenov, Rainer Fischer, et al.
Plos One|January 23, 2016
Development of a Competitive Cystatin C-Specific Bioassay Suitable for Repetitive MeasurementsTatjana Damm, Holger Spiegel, Stefan Barth, et al.
Toxins|October 30, 2012
Macrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseasesDmitrij Hristodorov, Radoslav Mladenov, Michael Huhn, et al.
Pageof 15